The 316,541-square-foot office building in unincorporated north St. Louis County sold for $36.5 million, according to real estate firm Cushman & Wakefield.
California's Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to “aggressively raise the list price of insulin in lockstep with each other to artificial levels.” Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products.